- Home
- TIL vs SUUN Comparison
TIL vs SUUN Comparison
Compare TIL & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- SUUN
- Stock Information
- Founded
- TIL 2018
- SUUN 2013
- Country
- TIL United States
- SUUN Canada
- Employees
- TIL N/A
- SUUN N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- SUUN
- Sector
- TIL Health Care
- SUUN
- Exchange
- TIL Nasdaq
- SUUN Nasdaq
- Market Cap
- TIL 171.7M
- SUUN 141.2M
- IPO Year
- TIL 2021
- SUUN N/A
- Fundamental
- Price
- TIL $22.12
- SUUN $4.35
- Analyst Decision
- TIL Strong Buy
- SUUN Strong Buy
- Analyst Count
- TIL 4
- SUUN 1
- Target Price
- TIL $114.00
- SUUN $6.00
- AVG Volume (30 Days)
- TIL 83.9K
- SUUN 400.4K
- Earning Date
- TIL 03-20-2025
- SUUN 02-14-2025
- Dividend Yield
- TIL N/A
- SUUN N/A
- EPS Growth
- TIL N/A
- SUUN N/A
- EPS
- TIL N/A
- SUUN N/A
- Revenue
- TIL N/A
- SUUN $36,247,013.00
- Revenue This Year
- TIL N/A
- SUUN $44.84
- Revenue Next Year
- TIL N/A
- SUUN $21.19
- P/E Ratio
- TIL N/A
- SUUN N/A
- Revenue Growth
- TIL N/A
- SUUN 43.76
- 52 Week Low
- TIL $9.62
- SUUN $1.95
- 52 Week High
- TIL $92.00
- SUUN $7.50
- Technical
- Relative Strength Index (RSI)
- TIL 48.67
- SUUN 54.91
- Support Level
- TIL $19.00
- SUUN $3.80
- Resistance Level
- TIL $25.80
- SUUN $5.94
- Average True Range (ATR)
- TIL 2.19
- SUUN 0.84
- MACD
- TIL 0.22
- SUUN -0.06
- Stochastic Oscillator
- TIL 45.88
- SUUN 43.01
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.